01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
I previously blogged about certain compensation related updates to ISS’ proxy voting guidelines for...
Read More >
On January 13, 2020, the U.S. Department of Labor issued a new rule revising its test for evaluating...
Read More >
As 2019 comes to an end, we are pleased to present our traditional End of Year Plan Sponsor “To Do”...
Read More >
Judicial Panel on Multidistrict Litigation Centralizes Some COVID‐19 Related Insurance Cases As rep...
Read More >
The NILG/OFCCP Compensation Roundtable provided an interesting exchange between OFCCP Representative...
Read More >
Congress recently passed the economic stimulus package referred to as the Coronavirus Aid, Relief, a...
Read More >